
Sign up to save your podcasts
Or
This week's episode is part 2 of a 2 part series addressing the changes in facility audits around regulations regarding diagnoses of schizophrenia in patients who have dementia. Dr Will Sampson, Director of Training and Clinical Education is joined this week by Dr Monica Leriger, Director of Pharmacy.
In Part 2 Dr. Sampson and Dr Leriger discuss the rationale behind reducing antipsychotics in our patient population.
Episode Producer: Kim Howell, Program Assistant for Training and Clinical Education
This week's episode is part 2 of a 2 part series addressing the changes in facility audits around regulations regarding diagnoses of schizophrenia in patients who have dementia. Dr Will Sampson, Director of Training and Clinical Education is joined this week by Dr Monica Leriger, Director of Pharmacy.
In Part 2 Dr. Sampson and Dr Leriger discuss the rationale behind reducing antipsychotics in our patient population.
Episode Producer: Kim Howell, Program Assistant for Training and Clinical Education